Brain stimulation for spinocerebellar ataxia type 3
Part of Brain & nervous system, Genetic & congenital clinical trials.
This trial tests a non-invasive brain stimulation method to see if it can improve movement and balance in people with spinocerebellar ataxia type 3. It aims to find the best settings for this treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have a confirmed diagnosis of spinocerebellar ataxia type 3 (SCA3) with symptoms.
- Your movement scores are within a specific range (SARA score 8-30, and gait score 2-6).
- You have a caregiver who can help you.
- You do not have severe memory problems or other conditions that would make it hard to report how you feel.
- You have not had seizures, brain surgery, or implanted devices like pacemakers or cochlear implants.
- You are not pregnant or breastfeeding, and use reliable birth control if applicable.
- You have not had brain stimulation treatments (like TMS or tDCS) in the past year.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a single injection of umbilical cord stem cells for adults with spinocerebellar ataxia, a condition that affects balance and coordination. The goal is to see if it can slow down or improve symptoms.
This study tests whether a non-invasive brain stimulation treatment (called cerebellar transcranial magnetic stimulation) can help improve balance and coordination in people with spinocerebellar ataxia. It may offer a new way to ease symptoms without surgery.
This study tests a brain pacemaker (called deep brain stimulation) placed in the cerebellum to help improve balance and coordination in people with SCA1 or SCA3. It aims to see if this treatment can reduce ataxia symptoms and improve daily function.
This study tests a new kind of deep brain stimulation that adjusts automatically to improve balance and coordination in adults with SCA6, a genetic form of ataxia. It may help patients who can still walk but have moderate to severe symptoms.
This trial tests a brain stimulation technique (tACS-iTBS) on the cerebellum to see if it can improve coordination and movement problems caused by ataxia. It might help if you have a stable medication routine and can follow instructions.
This trial tests an experimental stem cell treatment for people with SCA3, a genetic condition that affects balance and coordination. The goal is to see if the treatment can help improve or slow down these symptoms.
Hear when a new Spinocerebellar Ataxia Type 3 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.